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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYIn placental mammals, balanced expression of X-linked genes is accomplished by X chromosome inactivation (XCI) in female cells.
In humans, random XCI is initiated early during embryonic development. To investigate whether reprogramming of female human
fibroblasts into induced pluripotent stem cells (iPSCs) leads to reactivation of the inactive X chromosome (Xi), we have generated
iPSC lines from fibroblasts heterozygous for large X-chromosomal deletions. These fibroblasts show completely skewed XCI of the
mutated X chromosome, enabling monitoring of X chromosome reactivation (XCR) and XCI using allele-specific single-cell expression
analysis. This approach revealed that XCR is robust under standard culture conditions, but does not prevent reinitiation of XCI, resulting
in a mixed population of cells with either two active X chromosomes (Xas) or one Xa and one Xi. This mixed population of XaXa and
XaXi cells is stabilized in naive human stem cell medium, allowing expansion of clones with two Xas.INTRODUCTION
Inactivation of one of the two X chromosomes in eutherian
female cells byX chromosome inactivation (XCI) is an epige-
netic process,whichcompensates for potential dosagediffer-
ences of X-linked genes between female XX and male XY
cells (Lyon, 1961). Mechanistic and regulatory aspects of
XCI have been extensively studied during mouse develop-
ment and for mouse embryonic stem cells (mESCs). These
mESCs are derived from the inner cellmass (ICM)of the blas-
tocyst and contain two active X chromosomes (Xa), but will
undergo XCI upon in vitro differentiation. The noncoding
Xist RNA is crucial for XCI and becomes upregulated upon
differentiation of mESCs. Xist coats the future Xi, attracting
chromatin remodeling enzymes that infer the transcrip-
tional shutdownof theXi (reviewed inBarakat andGribnau,
2012; Pollex and Heard, 2012). Several components of the
regulatory network driving XCI are conserved between
mice and humans, but many questions regarding human
XCI remain unanswered. In contrast to undifferentiated
mESCs,mosthumanESC lines (hESCs) are inapost-XCI state
and are prone to epigenetic fluidity (Silva et al., 2008). This
variation in regulation and stability of theXCI state between
these eutherian speciesmight reflect suboptimal culture con-
ditions for thehumancells, resulting inagradualprogression
toward a more differentiated state, including initiation of
XCI. Alternatively, the XCI process itself may have reachedStem Cella more advanced state in the human ICM compared with
the mouse so that XCI in the hESCs derived from the ICM
has occurred already prior to or during ESC derivation.
The derivation of human induced pluripotent stem cells
(hiPSCs) from fibroblasts (Takahashi et al., 2007) offers new
opportunities to study XCI in human cells. For mouse fibro-
blasts, it has been shown that the Xi becomes reactivated
during the reprogramming process, followed by random
XCI (rXCI) upon differentiation of these miPSCs (Maherali
et al., 2007; Stadtfeld et al., 2008). Similar to studies
involving hESC lines, previous studies of XCI in hiPSCs
have provided varying results. Systematic analysis of multi-
ple female hiPSC lines derived from several fibroblast popu-
lations under different reprogramming strategies indicated
that all hiPSC lines retained the Xi inherited from the start-
ing fibroblasts (Amenduni et al., 2011; Ananiev et al., 2011;
Cheung et al., 2011; Tchieu et al., 2010). In another study,
it was found that in all hiPSC lines derived from one fibro-
blast population with established rXCI, one and the same
X chromosome had become the Xi in all lines, indicating
involvement of cell selection processes (Pomp et al., 2011).
In contrast, other studies showed reactivation of the Xi, an
apparent reversal of XCI that is herein referred to as X chro-
mosome reactivation (XCR), in all or a limited number of
hiPSC lines, but XCI was reinitiated upon differentiation of
these hiPSC lines (Bruck and Benvenisty, 2011; Kim et al.,
2011; Marchetto et al., 2010). XCR followed by reinitiationReports j Vol. 4 j 199–208 j February 10, 2015 j ª2015 The Authors 199
of XCI and stable establishment of the Xi upon hiPSC differ-
entiation is a crucial step that needs to take place for hiPSCs
to be applied for various purposes. If hiPSC lines do not pass
through this series of events, they showsignsof stochastic re-
activation of the Xi inherited from the founder fibroblasts
(Mekhoubad et al., 2012). This erosion of XCI is detrimental
for studies involving cell types generated from female
hiPSCs, as it can be expected that many of these cell types
will be prone to gene dosage inequalities. Therefore, the
availability of such hiPSC lines with stable XCR, having
two active X chromosomes as in mESCs, would greatly
advance research on modeling of X-linked human diseases
and studies on regulatory mechanisms of human XCI.
The varying results regarding XCR and XCI obtained for
hiPSCsmay be explained by different reprogramming tech-
niques and the growth conditions in which hiPSCs are
generated and maintained. In a recent study, it was found
that growth of hESCs and hiPSCs in defined conditions
(naive human stem cell medium [NHSM]) results in more
naive iPSCs and leads to efficient loss of Xi specificmarkers,
including XIST RNA and Xi-specific histone modifications,
which are re-established upon differentiation (Gafni et al.,
2013). Although these NHSM-cultured hESCs and hiPSCs
resemblemESCs andmiPSCs in several aspects, it is unclear
whether the described loss of Xi-specific markers under
these growth conditions has resulted in XCR, as expression
of X-linked loci was not assessed (Gafni et al., 2013).
Skewed rXCI is obtained in cells that carry a large X chro-
mosomal deletion on either one of the twoX chromosomes
outside the X inactivation center (XIC), based on selection
against cells that inactivate the intact X chromosome.
Here, we have generated and analyzed hiPSC lines derived
from female carriers with such heterozygous large X chro-
mosomal deletions, which were expanded under different
growth conditions (standard versus NHSM). These hiPSCs
provide a powerful model system to study XCR and XCI,
facilitated by allele-specific expression analysis. Single-cell
expression analysis of these hiPSC lines, when generated
under standard culture conditions, revealed robust XCR,
which was followed by XCI. Hence, the presence of two
active X chromosomes in these hiPSCs is not a stable con-
dition, as it is in undifferentiated mESCs. However, growth
of the present hiPSC lines in NHSM conditions did stabilize
the equilibrium between XCR and XCI over several pas-
sages and allowed rapid expansion of hiPSC lines with
two active X chromosomes.RESULTS
Cell Lines with Non-rXCI for hiPSC Formation
To generate novel hiPSC lines to investigate XCR and XCI
during reprogramming at a single-cell level, we screened200 Stem Cell Reports j Vol. 4 j 199–208 j February 10, 2015 j ª2015 The Acell repositories for female cell lines harboring large dele-
tions on one of the X chromosomes. Because of secondary
selection, an X chromosome with a large deletion is prefer-
entially inactivated in female carriers, providing a sensitive
assay to identify hiPSC lines that have reactivated theXi in-
herited from the founder fibroblasts, which results in bial-
lelic expression of polymorphic informative genes.
Cell lines were collected through different sources, and
the gene content was further characterized by multiplex
ligation-dependent probe amplification, single nucleotide
polymorphism (SNP) array, and DNA-FISH analysis (Fig-
ures 1A, 1B and S1; Table S1). The fibroblast lines X12,
X14, and X15 containing informative large deletions of
Xq were selected for further studies examining XCR and
XCI. The respective deletions concern regions outside
the XIC. Deletions including the XIC would block XCI of
the X chromosome carrying the deletion, whereas large
deletions that do not include the XIC will lead to clonal
selection of the cells that have inactivated the mutant X
chromosome, keeping the intact X chromosome as the
Xa. In addition, 46,XX fibroblasts not carrying an X-chro-
mosomal deletion and 47,XXX fibroblasts derived from a
patient with triple X syndrome were included as controls
(Brosens et al., 2014). RNA-FISH analysis indicated that in
fibroblast cell lines X12, X14, and X15, 99% of the cells
showed oneXISTcloud per nucleus (Figure 1C; n = 200 cells
analyzed per cell line). In the 47,XXX fibroblasts, two XIST
clouds marking two inactive X chromosomes were found
in almost every cell (Figure 1C), in agreement with the
rule that all but one X chromosome becomes inactivated
per diploid genome (Harnden, 1961). HUMARA analysis
amplifies a polymorphic region in the androgen receptor
(AR) gene after digestion with a methylation sensitive
enzyme and is used to detect the methylated Ar allele
marking the Xi (Allen et al., 1994). This analysis indicated
that rXCI is completely skewed toward inactivation of one
of the two X chromosomes, for all three X12, X14, and X15
fibroblast cell lines (Table S1). Both in the 46,XX and the
47,XXX fibroblast cell lines, rXCI without such skewing
was observed (Table S1) (Brosens et al., 2014). Preferential
inactivation of one specific X chromosome in fibroblast
line X12 was confirmed by RFLP RT-PCR analysis of a SNP
in XIST (Figure 1D). Although no informative SNPs were
available for XIST in the X14 and X15 fibroblast cell lines,
analysis of X-linked genes showed completely skewed
XCI in both cell lines (Figure S1D). We conclude that the
X12, X14, and X15 fibroblast cell lines show highly skewed
rXCI, most likely silencing the X carrying the deletion.
Generation of hiPSC Lines
To generate hiPSC lines, X12, X14, X15, 46,XX, and
47,XXX fibroblasts were transduced with a polycistronic
lentiviral vector expressing OCT4, SOX2, KLF4, and MYC,uthors
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Figure 1. Fibroblast Cell Lines with Skewed rXCI
(A) Schematic representation of the human X chromosome. The location of genes analyzed in this study is indicated. The dashed lines
indicate the deletions in the X12, X14, and X15 fibroblast cell lines. Also DNA-FISH probes are indicated.
(B) DNA-FISH on metaphase chromosomes of X12 and X15 fibroblasts, using probes 1, 2, 3, and 4. Magnification of X chromosomes is shown
in the insets.
(C) RNA-FISH detecting XIST RNA (FITC) in X12, X14, X15, and 47,XXX fibroblasts. DNA is counterstained with DAPI (blue, scale bar
represents 10 mm).
(D) PCR and RT-PCR analysis with DNA and cDNA from X12, X14, and X15 fibroblast cell lines, amplifying an RFLP in XIST. PCR products were
digested with MfeI to discriminate between both alleles.and a dTomato reporter, under the control of a retroviral
promoter (SFFV) that is rapidly silenced during the reprog-
ramming process (Warlich et al., 2011) (Figures 2A and 2B).
These fibroblasts were plated on mouse embryonic fibro-
blasts and cultured in the presence of standard hESC me-Stem Celldium. After approximately 10 days, small clusters of cells
appeared that started to develop an hESC morphology.
These clusters gradually lost the expression of the dTomato
reporter (Figures 2B and S2A), which indicated proper
silencing of the lentiviral transgene, required to establishReports j Vol. 4 j 199–208 j February 10, 2015 j ª2015 The Authors 201
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Figure 2. Generation of hiPSC Lines from Fibroblasts
(A) Schematic overview of the lentiviral reprogramming cassette (Warlich et al., 2011) and the procedure at 10 and 22 days after
transduction, to establish the present hiPSC lines.
(B) Transduced fibroblasts express dTomato (left), which is silenced upon proper reprogramming (right, scale bar represents 100 mm).
(C) Representative picture of a hiPSC colony (p3 denotes passage 3) from iPSC line X12-2 (left, scale bar represents 100 mm), and karyogram
of iPSC X12-2, revealing a 46,XX karyotype (right).
(D) Representative picture of EBs derived from iPSC line X12-2 after 8 days of differentiation (scale bar represents 100 mm).
(E) qRT-PCR analysis of pluripotency factors in X12 hiPSC lines (1–6). Expression of the same factors in an hESC line (H9) served as a control
and was set at 100%.
(F) qRT-PCR analysis of differentiation associated markers in day 8 (d8) EBs from X12 hiPSC lines. Gene expression was normalized to a
differentiated hESC line H9.fully reprogrammed hiPSCs. For each one of the different
genotypes, we obtained several iPSC lines, of which the
X12, X15, 46,XX, and 47,XXX iPSC lines were subjected
to further analysis. All of these iPSC lines showed mor-
phology resembling hESCs, with a stable 46,XX karyotype
(or 47,XXX in case of lines derived from the 47,XXX fibro-
blasts) and expression of key endogenous pluripotency fac-
tors, including NANOG and REX1, at different passages (p)
after establishment (Figures 2C–2E, S2C, and S2D; data not
shown). Also, SNP arrays of various hiPSC lines confirmed202 Stem Cell Reports j Vol. 4 j 199–208 j February 10, 2015 j ª2015 The Aan identical genome content compared with the founder
fibroblasts (Figure S2D). Upon embryoid body (EB) dif-
ferentiation, qPCR analysis indicated thatmost hiPSC lines
showed expression of endodermal (FLK1, AFP), meso-
dermal (GATA2), and ectodermal (PAX6) marker genes (Fig-
ure 2G, only X12 clones are shown). This was confirmed
by immunocytochemistry analysis on EB-differentiated
iPSCs plated on slides, revealingGFAP (ectoderm),Vimentin
(mesoderm), and AFP-positive cells for all iPSC lines, which
supports our conclusion that all iPSC clones wereuthors
CA
E FD
  50
40
30
20
10
%
 c
el
ls
 w
ith
 X
i 
XIST + H3K27me3
XIST only
H3K27me3 only
 X12-1  X15-2 X12-2  X12-3  X12-4
  50
40
30
20
10
%
 c
el
ls
 w
ith
 X
i
 2  4
1 XIST cloud 
2 XIST clouds 
 3
47,XXX
G
XIST MfeI
M
A
B
B
47
,X
X
X
-4
X
12
-2
X
12
-4
B
B
A
XIST MfeI
M X
12
-1
X
12
-2
X
12
-3
X
12
-4
X
12
-5
H
iPSC line 47, XXX-3
H
3K
27
m
e3
 / 
 X
IS
T
H
3K
27
m
e3
 / 
 X
IS
T 
/ D
A
PI
iPSC X line12-2 iPSC line X15-2
B
iPSC line X12-1
D
A
PI
U
D
H
3K
9a
ce
t /
  X
IS
T
/ D
A
PI
H
3K
27
m
e3
 / 
XI
ST
/ D
A
PI
X12-1 middle X12-1 edge
X12-3 middle X12-3 edge
% allele 2
X12 fibroblast 0,0 100,0
X12-1 p3 2,6 97,4
X12-2 p3 12,0 88,0
X12-3 p3 5,3 94,7
X12-4 p3 1,5 98,5
X12-5 p3 2,6 97,4
X12-6 p3 3,0 97,0
X15 fibroblast 100,0 0,0
X15-1 p5 100,0 0,0
X15-2 p5 100,0 0,0
% allele 1
skewing ratio
Figure 3. XCI Analysis of hiPSCs
(A) Immuno-RNA-FISH analysis on hiPSC lines X12-2, X15-2, and 47,XXX-3 (all cells in A–E and G, passage 3), detecting XIST (Rhodamine
Red) and H3K27me3 (FITC). In the upper panels, the nuclei are counterstained with DAPI (scale bar represents 10 mm).
(B) Example of an X12-1 hiPSC clone, at lower magnification. The center part and edge of colony are indicated with D, the undifferentiated
middle part of the colony with an U (scale bar represents 100 mm).
(C) Immuno-RNA-FISH detecting XIST (Rhodamine Red) and H3K9ac (FITC, top) and detecting XIST (Rhodamine Red) and H3K27me3 (FITC,
bottom) on cells found in U (left) and in D (right) (scale bar represents 10 mm).
(D) Quantification of immuno-RNA-FISH analysis of representative hiPSC lines X12 (1–4) and X15-2. Percentages of cells with both an XIST
cloud and H3K27me3 accumulation, only an XIST cloud, or only H3K27me3 accumulation are shown (mean ± SD, n = 3 experiments, >100
cells were counted per experiment).
(E) Quantification of immuno-RNA-FISH analysis of representative hiPSC lines 47,XXX (2–4). Percentage of cells with either one or two XIST
clouds is plotted (mean ± SD, n = 3 experiments, >100 cells were counted per experiment).
(F) Quantification of all HUMARA analyses performed with different fibroblast and hiPSC lines, passages 3 and 5 (p3 and p5).
(G) Allele-specific RT-PCR analysis of XIST. PCR products were digested using MfeI to distinguish between both parental alleles. The hiPSC
lines X12-2 and X12-4 show biallelic XIST expression, which was not found in the original fibroblast line (compare to Figure 1D).
(H) As for (G), but here day 8 differentiated X12 hiPSC lines are assessed.completely reprogrammed and acquired full differentia-
tion potential (Figure S2B; results of one representative
X12 clone are shown).
Early Passage Female hiPSCs Show Reactivation
of the Xi
The X12, X15, and 47,XXX iPSCs were subjected to im-
muno-RNA-FISH analysis at passages 3–5 to investigate
the XCI status of these cell lines. This analysis showed
that in several iPSC lines generated from the X12 and X15
fibroblasts only 30% of the nuclei displayed XIST-coated
X chromosomes (Figures 3A and 3D). In hiPSC lines ge-
nerated from the 47,XXX fibroblasts, many cells did not
show Xi markers or showed signs of only one Xi (Figures
3A and 3E). In all cell lines, analysis of heterochromatinStem Cellmarkers associated with the Xi, including enrichment of
H3K27me3, indicated variable staining, with many cells
not displaying all characteristic Xi features (Figure 3A;
datanot shown). Also, Barr bodies (e.g.,DAPI-dense, hetero-
chromatic regions covering the Xi) were detected in a mi-
nority of cells. Strikingly, in many colonies, cells with all
Xi hallmarks, including depletion of H3K9ac, were most
often found at the edges or in the center of the colonies,
wheremost of the differentiated cells are found. In contrast,
cells without XIST and associated Xi markers were found in
a donut-shaped region surrounding the middle of the col-
onies (Figures 3B and 3C).These results could be explained
by (1) loss of X chromosome(s), (2) loss of XIST expression
and Xi markers during hiPSC cell culture and colony for-
mation, similar to findings for hESC lines (Bruck andReports j Vol. 4 j 199–208 j February 10, 2015 j ª2015 The Authors 203
Benvenisty, 2011), or (3) XCR in a pluripotent subpopula-
tion of hiPSCs, possibly followed by XCI. Option 1 was
excluded, as karyotyping and SNP array analysis did not
reveal a significant population of cells with X chromosome
aneuploidies at different passages after establishment of the
iPSC lines. To distinguish between options 2 and 3, we first
analyzed the methylation pattern of the Xi by HUMARA
analysis, focusing on the hiPSC lines derived from the
X12 and X15 fibroblasts. If the Xi in the hiPSCs is the
same X chromosome as the Xi inherited from the founder
fibroblasts, HUMARA analysis will detect completely
skewed methylation of the Ar gene. Furthermore, using
this analysis, XCR in all cells would lead to an absence of
methylation at the Ar gene, whereas XCR followed by
rXCI, which might also involve the intact X chromosome
would result in methylation of the previously unmethy-
lated AR allele. HUMARA analysis for genomic DNA of un-
differentiated X15 hiPSC lines showed the initial 100:0
skewing ratio (Figure 3F), which was also observed for the
founder fibroblast cell line, compatible with either an
absence of XCR, or XCR in a small subpopulation of cells
that cannot be detected by thismethod. In undifferentiated
X12 p3 hiPSC lines, we observed methylation, in some
clones up to 12%, also of the second Ar allele located on
the intact X chromosome (Figure 3F). This finding indicates
that XCR in the X12 p3 hiPSCs is unstable and that these
cells have started rXCI also on the intact X chromosome
in a subpopulation of cells. We next performed allele-spe-
cific expression analysis ofXISTusing RFLP RT-PCR analysis
on RNA from X12 hiPSCs, the only hiPSC line with an
informative XIST SNP. On the whole cell population level,
we detected XIST expression from both X chromosomes
(Figure 3G). This supported the findings with the HUMARA
analysis, indicating thatXISTupregulation and initiation of
XCI have occurred following XCR, in X12 hiPSC lines. In
the day 8 differentiated progeny of X12 hiPSC lines, we de-
tected monoallelic XIST expression (Figure 3H) comparable
to that in the original X12 fibroblasts. This is explained by
survival, at later passages, of cells that have silenced the
mutant X chromosome and loss of cells that have initiated
XCI on the intact X chromosome.
Biallelic Expression of X-Linked Loci and Reversal
of XIST Expression
The observed presence of XIST-negative cells within
colonies at early passages of the X12 hiPSC lines is in agree-
ment with the present findings for the whole-cell popula-
tions with the HUMARA assay and XIST expression anal-
ysis. Taken together, the results provide evidence that the
hiPSCs, cultured under the above standard conditions,
engage in both XCR and subsequent initiation of XCI.
To precisely evaluate the dynamics of XCR,we performed
allele-specific single-cell RT-PCR analysis, amplifying RFLPs204 Stem Cell Reports j Vol. 4 j 199–208 j February 10, 2015 j ª2015 The Ain the X-linked genes XIST, SUVAR39H1, and G6PD at
different time points after reprogramming. X12 iPSC and
47,XXX iPSC lines were sorted via fluorescence-activated
cell sorting (FACS) in 96-well plates using antibodies
against the pluripotency-associated surface markers SSEA4
and Tra1-81 at p0, p3/4, and p25 after establishment. All
sorted cells were dTomato negative. Passage 0 cells were
isolated 20 days after the start of the reprogramming proce-
dure, prior to picking. For all time points, the SSEA4 and
Tra1-81 double-positive fraction represented more than
40% of the total viable cell fraction (Figure 4A; data not
shown), and qPCR analysis showed increased expression
of the pluripotency markers in pooled double-positive
SSEA4+/Tra1-81+ and GCTM2+/CD9+ sorted cells (Fig-
ure 4B). SSEA4+/Tra1-81+ double-positive (dTomato) cells
were sorted in lysis buffer, and single-cell nested RT-PCR
was performed, followed by restriction digestion to distin-
guish between expression from the different alleles. Anal-
ysis of XIST in X12 hiPSCs revealed a high percentage of
cells not expressing XIST and cells displaying expression
of XIST emanating from the Xa (allele B) at all stages after
reprogramming (Figures 4D and 4E). Also, allele-specific
expression analysis of X-linked SUVAR39H1 revealed a
high percentage of cells displaying expression of the previ-
ously inactive allele B (Figure S3). Interestingly, only a small
percentage of cells displayed XIST and SUVAR39H1 expres-
sion both exclusively from the alleles A, as was found for
the founder fibroblasts used to generate the iPSCs (Figures
4C–4E and S3). In addition, the percentage of cells ex-
pressing only the XIST and SUVAR39H1 alleles A did not
markedly drop after establishment of the iPSC line. Similar
results were obtainedwith iPSCs generated from 47,XXXfi-
broblasts analyzed at p0 and p25, revealing a considerable
amount of cells that showed biallelic expression of G6PD,
indicating reactivation of the Xi (Figure 4E). These results
indicate robust reactivation of theXi during the early stages
of the reprogramming process. In addition, the results of
the RNA-FISH analysis on iPSC clones X12-2 and X12-4
suggest that in most cells expressing XIST this RNA is de-
tected only at very low levels (Figures 3D and 4E). To test
whether XCR involved multiple genes on the X chromo-
some, we performed allele-specific expression analysis of
three additional informative genes located at different posi-
tions on the X. RNA was isolated from pooled cells of
different X12 clones. In two of the three tested iPSC clones
(X12-23 and X12-24), we found biallelic expression of
HUWE1, ATP7A, and NROB1, whereas in the iPSC line
X12-19 only NROB1 expression was biallelic (Figure S4),
indicating that the robustness of XCR is variable between
clones.
Recently, hESCs and hiPSCs have been generated with
more naive characteristics closely resembling the mouse
mESCs (Gafni et al., 2013). Naive hiPSC lines wereuthors
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Figure 4. Single-Cell RT-PCR Analysis of Sorted hiPSCs
(A) FACS analysis of hiPSCs stained for the pluripotency-associated surface markers SSEA4 and TRA1-81 (gate used to sort hiPSCs is shown).
(B) qRT-PCR analysis of NANOG in living sorted H9 ESCs, and X12-2 and 47,XXX-4 hiPSCs, comparing unsorted cells (U), SSEA4/TRA1-81
double-negative cells, CD9+/GCTM2+ double-positive cells, and SSEA4+/TRA1-81+ double-positive cells. Results are normalized for GAPDH.
NANOG expression in unsorted H9, the positive control, was set at 100.
(C) Allele-specific expression analysis of SUVAR39H1 on gDNA and cDNA isolated from X12 fibroblasts.
(D) Single-cell RT-PCR analysis of SSEA1+/TRA1-81+ sorted cells from hiPSC line X12-2 (passage 25, p25). Shown are the cells numbered 49–
60. Allele-specific expression of XIST and SUVAR39H1 was assessed by digestion with MfeI and MspI, distinguishing the parental alleles
(indicated with A and B).
(E) Quantification of (D) for XIST (left graph) and SUVAR39H1 (middle graph) on X12 iPSC lines (X12-2 up to X12-24, and the pooled cells)
at different passages (p0 up to p25) after reprogramming. The right graph shows the quantification of allele-specific expression analysis of
G6PD on SSEA4+/Tra1-81+ sorted 47,XXX iPSCs (for all experiments n = 96 cells per cell line).
(F) Dome-shaped morphology of NHSM cultured hiPSCs (scale bar represents 100 mm).
(G–K) TRA1-81 (G), ID3 (H), and STAT3 (I) expression is increased, and DNMT3A (J) and DNMT3B (K) expression is decreased in NHSM-
cultured iPSC lines. Shown is the mean intensity of TRA1-81 determined by FACS analysis. For ID3, STAT3, DNMT3A, and DNMT3B expression
per iPSC line is shown relative to H9 hESCs cultured in human ES medium.
(L) XIST expression analysis as in (H)–(K).
(M) XIST RNA-FISH analysis on X12-23 iPSCs grown in NHSM, passage 6 (>100 cells were counted per experiment, scale bar represents
10 mm).
(N) Quantification of cells with XIST-coated X chromosomes in different X12 iPSC lines (p6).
(O) Allele-specific expression analysis of XIST and SUVAR39H1 at different passages (p0–p4) of X12 hiPSC lines growing in NHSM (alleles A
and B, as in Figure 4D).established by reprogramming human fibroblasts inNHSM
medium, but could also be generated by culturing hiPSCs
established in standard hESC medium in NHSM. To testStem Cellwhether NHSM medium would enhance XCR in our
iPSCs, we passaged (p3/4) four different hiPSC lines in
NHSM medium, which already at passage one resulted inReports j Vol. 4 j 199–208 j February 10, 2015 j ª2015 The Authors 205
morphologically mouse-like hiPSCs that could be passaged
through trypsinization (Figure 4F). FACS and qRT-PCR
analysis indicated that expression of TRA1-81, ID3, and
STAT3 was upregulated and that expression of DNMT3A
and DNMT3B was downregulated in NHSM culture condi-
tions as described (Gafni et al., 2013) (Figures 4G–4K).
Other tested markers, including TEAD4 and DUSP10, did
not show consistent changes. XIST RNA-FISH and qRT-
PCR analysis on these hiPSC lines, fixed after six passages
in NHSM, indicated a near loss of XIST clouds and XIST
expression in most lines (Figures 4L–4N), consistent with
reported findings (Gafni et al., 2013). Allele-specific RT-
PCR analysis indicated no change in the allelic expression
ratio of XIST after culturing the hiPSCs in NHSM, with
different iPSC lines showing either biallelic or monoallelic
expression of XIST (Figure 4O). For most clones, the allele-
specific expression ratio of SUVAR39H1 was stable
throughout several passages in NHSM. Also, allele-specific
expression analysis of HUWE1, ATP7A, and NROB1, on
three different X12 iPSC lines, indicated no change in the
expression status before and after transfer to NHSM. These
findings indicate that culture of the hiPSC lines in NHSM
does not have an effect on XCR, but reduces XIST expres-
sion. This indicates that indeed a further shift toward stable
XCR in hiPSCs can be obtained by culturing iPSCs in
NHSM.DISCUSSION
Here, we have investigated the dynamics of XCI in hiPSCs
derived from human female fibroblast cultures with
completely skewed rXCI. This approach allowed us to
include analysis of XCR and XCI at the single-cell level.
The present results show that, at the single cell level, reprog-
ramming of human cells into hiPSCs results in XCR, even at
early passages. Biallelic expression of different X-linked loci
indicates that the Xi is reactivated in a large part of the cell
population of our hiPSC lines, but is variable between iPSC
lines. In several hiPSC lines, we also detected XIST expres-
sion and expression of several X-linked genes from the allele
that was not active in the starting fibroblast culture. Human
iPSC lines share a clonal origin, and therefore, this switch in
expression from one allele to the other, or biallelic expres-
sion, indicates that during the reprogramming process
XCR must have occurred in a high proportion of cells. Dif-
ferentiation of hiPSCs was found to result in completely
skewed rXCI, similar to that of the starting fibroblast popu-
lation, indicating a high selective pressure against cells that
have inactivated the intact X chromosome.
A recent study indicated that XIST expression can be lost
upon prolonged passaging of female hiPSCs, referred to as
‘‘erosion of XCI’’ (Mekhoubad et al., 2012). This epigenetic206 Stem Cell Reports j Vol. 4 j 199–208 j February 10, 2015 j ª2015 The Aerosion was found to be irreversible and correlated with a
loss of differentiation characteristics and is very relevant
for disease-modeling procedures. Erosion of XCI in hiPSC
lines can be effectively prevented by XCR followed by
XCI upon differentiation. Several studies have been pub-
lished assessing XCR during the reprogramming process.
Derepression attributed to XCR of genes located on the Xi
has been observed in hESC lines (Lengner et al., 2010)
and has been reported in studies involving gene expression
profile comparisonofmultiple femalehESCandhiPSC lines
(Bruck and Benvenisty, 2011). Very recently, XCR was
shown to happen efficiently early during reprogramming
of human cells, but that this was quickly followed by initi-
ation of XCI upon generation of nascent hiPSC lines, lead-
ing to XaXi cells only (Kim et al., 2014). These authors
concluded that XCR was the result of overexpression of
the exogenous reprogramming factors and that shutdown
of the reprogramming cassette leads to XCI initiation.
In contrast, our study indicates that in the present
reprogramming and culture conditions, hiPSCs maintain
the XaXa state in a high percentage of cells in the absence
of ectopic expression of the reprogramming factors. The
present single-cell allele-specific expression analysis re-
vealed expression of the SUVAR39H1, HUWE1, ATP7A,
NROB1, and G6PD alleles located at different positions on
the X chromosome that was the Xi in the starting fibro-
blasts, in a high (>50%) proportion of cells of X12 and
47,XXX hiPSC lines. This effect was already present
20 days after transduction, arguing against erosion of XCI
in our hiPSC lines and favoring XCR of the silenced Xi
upon reprogramming. Our studies also showed that XaXa
cells represent the major population of cells at all stages af-
ter reprogramming, indicating that the present experi-
mental conditions prevented robust precocious initiation
of XCI, but allowed cells to maintain either the XaXa or
the XaXi situation. The present findings would be in agree-
ment with the suggestion that culturing hiPSCs in naive
growth conditions facilitatesXCR,whichwasnot addressed
in this initial report (Gafni et al., 2013). Indeed, our studies
indicate that NHSM growth conditions effectuate a reduc-
tion in the percentage of cells with XIST-coated X chromo-
somes. However, this does not lead to changes in the allele-
specific expression ratio of SUVAR39H1, HUWE1, ATP7A,
and NROB1 in most hiPSC lines, and although we only
analyzed our cells at an early stage after changing to the
NHSM condition (passage 4), these findings suggest that
XCR and XCI characteristics are hiPSC line specific and es-
tablished during reprogramming and cannot be changed af-
terward. Recently, two other protocols have been described
to revert primed into naive hESCs (Takashima et al., 2014;
Theunissen et al., 2014). Surprisingly, one study reports
initiation of XCI after induction of the naive state (Theunis-
sen et al., 2014), whereas another study indicates loss ofuthors
XISTandH3K27me3 accumulation after a reset of primed to
naive ESCs (Takashima et al., 2014). These findings empha-
size that knowledge about the transcriptional status of the
X chromosomes in the ICM of the female preimplantation
human embryo will be crucial to conclude which of these
conditions result in hESCs that resemble ICM cells most.
The results presented herein strongly suggest that XCR of
the Xi is an important first step in reprogramming of hu-
man female fibroblasts and demonstrate that rXCI is often
de novo initiated during the culture of the generated hiPSC
lines, most likely triggered by partial differentiation of the
hiPSCs. In addition, we found that XCR appears to occur
remarkably efficient under standard reprogramming condi-
tions and that subsequent NHSM culture conditions stabi-
lize this XaXa state. This facilitates rapid expansion and ge-
netic manipulation of established female hiPSC lines with
two active X chromosomes, to be used for various applica-
tions, in particular disease modeling, offering differenti-
ated cell types that have newly established an Xi, thereby
avoiding effects related to erosion of XCI. Furthermore,
this provides us with a powerful model system to study hu-
manXCI, allowing us to examine the effects of a wide spec-
trum of X-linked mutations and deletions on XCI.EXPERIMENTAL PROCEDURES
Cell Lines
GM07148 (X12), GM03923 (X14), andGM03827 (X15) fibroblasts
were obtained from the Corriel cell repository, and 47,XXX fibro-
blasts were established from a skin biopsy of a triple X patient
(Brosens et al., 2014). All fibroblast were cultured in standard fibro-
blast medium.
hiPSC Generation and Culture
To generate iPSCs, human fibroblasts from lines X12 (p12), X15
(p4), and 47,XXX (p14) were reprogrammed according to Warlich
et al. (2011), with minor modifications. NHSM medium and
culture conditions were as described by Gafni et al. (2013).
Detailed information is provided in the Supplemental Experi-
mental Procedures.
Immuno-RNA-FISH Analysis
Detailed protocols and probes for RNA-FISH and immuno-RNA-
FISH have been described (Barakat and Gribnau, 2014; Barakat
et al., 2011; Jonkers et al., 2009). For immunostainings, the
following antibodies were used: anti-Nanog (1:100, Abcam), anti-
KLF4 (1:250, Abcam), anti-H3K27me3 (1:500, Diagenode), anti-
H3K4me3 (1:1000, Upstate), anti-H3K9ac (1:1000, Sigma),
anti-CD9 (Invitrogen), anti-GCTM2 (BD), anti-SSEA4 (BD), and
anti-TRA1-80 (BD).
RT-PCR and Single-Cell RT-PCR
All primers used are described in Table S2. For single-cell RT-PCR,
SSEA1+/TRA1-81+ double-positive cells were sorted via FACS inStem Cell96-well plates containing 9 ml lysis buffer using a BD FACSAria
apparatus. Lysis buffer consisted of 8 ml 2xReaction mix (Super-
Script One-Step RT-PCR kit; Invitrogen), 10 U RNaseOut (Invitro-
gen), and 0.15% IGEPAL CA-630 (Sigma). cDNA was prepared
with gene-specific outer primers and further processed as
described in the Supplemental Experimental Procedures. PCR
products were precipitated and digested with the indicated re-
striction enzymes (New England Biolabs) to distinguish expres-
sion from the different alleles. RFLPs in XIST, SUVAR39H1,
G6PD, and SNPs in HUWE1, NROB1, and ATP7A were identified
by PCR amplification and Sanger sequencing, followed by
allele-specific expression analysis using cDNA-specific primer
sets described in Table S2.
SNP Array and HUMARA Analysis
Tomap the deletions in our fibroblast cell lines, SNP array was per-
formed using Human CYTO SNP 12 version 1 arrays (Illumina),
aligned to human genome build 18. A detailed description of the
HUMARA assay applied to determine skewing of XCI is provided
in the Supplemental Experimental Procedures.
DNA-FISH Analysis
To visualize the deletion in cell lines, DNA-FISH was performed
according to standard procedures. Probes used were BAC CTD-
3076O23 (BAC1FITC, Xq23, 108,9 Mb, HG19), RP11-799O20
(BAC2, A595, Xq25, 123 Mb), RP11-75N13 (BAC3, FITC, Xq21.1,
84,5 Mb), and RP1-279N11 (BAC4, A595, Xq13.3, 75,8 Mb).
Statistics and qRT-PCR Analysis
For qRT-PCR expression analysis, the average and SD of three bio-
logical replicates are shown.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, and two tables and can be found with
this article online at http://dx.doi.org/10.1016/j.stemcr.2014.12.
012.
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